Skip to main content
SpringerLink
Log in

Antineoplastic drugs

Lack of efficacy and drug resistance: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zheng W, et al. Efficacy of osimertinib in a metastatic lung adenocarcinoma patient harboring somatic EGFR delL747_S752 and germline BIM deletion polymorphism: a case report and literature review. Translational Cancer Research 11: 3895-3902, No. 10, Oct 2022. Available from: URL: http://doi.org/10.21037/tcr-22-1050

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastic drugs. Reactions Weekly 1940, 49 (2023). https://doi.org/10.1007/s40278-023-31907-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-31907-5

Search

Navigation